Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma

被引：14
|
作者：
Kim, Jung Guk [1 ]
机构：
[1] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, 680 Gukchaebosang Ro, Daegu 700842, South Korea
来源：
ENDOCRINOLOGY AND METABOLISM | 2014年 / 29卷 / 03期
关键词：
Thyroid neoplasms; Targeted therapies;
D O I：
10.3803/EnM.2014.29.3.211
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Four proto-oncogenes commonly associated with well-differentiated thyroid carcinoma, rearranged during transfection (RET)/papillary thyroid cancer, BRAF, RAS, and PAX8/peroxisome proliferator activated receptor-., may carry diagnostic and prognostic significance. These oncogenes can be used to improve the diagnosis and management of well-differentiated thyroid carcinoma. Limited therapeutic options are available for patients with metastatic well-differentiated thyroid cancer, necessitating the development of novel therapies. Vascular endothelial growth factor (VEGF)-and RET-directed therapies such as sorafenib, motesanib, and sunitinib have been shown to be the most effective at inducing clinical responses and stabilizing the disease process. Further clinical trials of these therapeutic agents may soon change the management of thyroid cancer.
引用
收藏
页码：211 / 216
页数：6
相关论文
共 50 条
  • [31] UPPER AIRWAY INVASION BY WELL-DIFFERENTIATED THYROID-CARCINOMA
    DONNELLY, MJ
    CONSIDINE, N
    MCSHANE, DP
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1993, 107 (08): : 752 - 754
  • [32] INDICATIONS FOR BILATERAL NECK DISSECTION IN WELL-DIFFERENTIATED CARCINOMA OF THE THYROID
    NOGUCHI, M
    HASHIMOTO, T
    OHYAMA, S
    TAJIRI, K
    FUJII, H
    MIYAZAKI, I
    JAPANESE JOURNAL OF SURGERY, 1987, 17 (06): : 439 - 444
  • [33] TREATMENT OF WELL-DIFFERENTIATED CARCINOMA OF THE THYROID BASED ON INITIAL STAGING
    DUFFIELD, RGM
    LOWE, D
    BURNAND, KG
    BRITISH JOURNAL OF SURGERY, 1982, 69 (07) : 426 - 428
  • [34] Well-Differentiated Thyroid Carcinoma: Comparison of Microscopic and Macroscopic Disease
    Tzvetov, Gloria
    Hirsch, Dania
    Shraga-Slutzky, Ilana
    Weinstein, Ruth
    Manistersky, Yosi
    Kalmanovich, Ronit
    Lapidot, Mordechai
    Grozinsky-Glasberg, Simona
    Singer, Joelle
    Sulkes, Jaqueline
    Shimon, Ilan
    Benbassat, Carlos
    THYROID, 2009, 19 (05) : 487 - 494
  • [35] RADIOIODINE THERAPY IN WELL-DIFFERENTIATED PAPILLARY AND FOLLICULAR CARCINOMA OF THYROID
    VARMA, VM
    REBA, RC
    JOURNAL OF NUCLEAR MEDICINE, 1978, 19 (06) : 714 - 715
  • [36] COMPLETION THYROIDECTOMY IN THE MANAGEMENT OF WELL-DIFFERENTIATED THYROID-CARCINOMA
    WAX, MK
    BRIANT, TDR
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1992, 107 (01) : 63 - 68
  • [37] Cervical lymph node metastases in well-differentiated thyroid carcinoma
    McQuone, SJ
    Eisele, DW
    HEAD AND NECK CANCER, VOL 4, 1996, : 967 - 971
  • [38] OCCULT DISTANT METASTASES OF WELL-DIFFERENTIATED THYROID-CARCINOMA
    ZOHAR, Y
    STRAUSS, M
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1994, 16 (05): : 438 - 442
  • [39] Usefulness of ultrasound in the diagnosis and management of well-differentiated thyroid carcinoma
    de Camargo, Rosalinda Y. A.
    Tomimori, Eduardo Kiyoshi
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (05) : 783 - 792
  • [40] Changing trends in the management of well-differentiated thyroid carcinoma in Korea
    Lee, Yong Sang
    Chang, Hang-Seok
    Park, Cheong Soo
    ENDOCRINE JOURNAL, 2016, 63 (06) : 515 - 521
12345